J. Carroll
Vorsitzender bei ESPERION THERAPEUTICS, INC.
Vermögen: 2 Mio $ am 31.05.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| John Chiminski | M | 60 |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 15 Jahre |
| Alessandro Maselli | M | 52 | 14 Jahre | |
| Nicole Vitullo | F | 66 | 16 Jahre | |
| Ricky Hopson | M | 48 | 3 Jahre | |
| Sheldon Koenig | M | 58 | 4 Jahre | |
| Mark Tyndall | M | 48 | 10 Jahre | |
| Seth Fischer | M | 68 | 8 Jahre | |
| Chinh Chu | M | 57 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 17 Jahre |
| Joseph Ferraro | M | 47 | 1 Jahre | |
| Rosemary Crane | F | 64 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 6 Jahre |
| Jack Stahl | M | 71 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 10 Jahre |
| John Greisch | M | 69 | 6 Jahre | |
| Stephanie Okey | F | 64 | 1 Jahre | |
| Scott Gunther | M | 57 | 12 Jahre | |
| Kay Schmidt | F | 66 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 15 Jahre |
| Ricardo Pravda | M | 53 | 19 Jahre | |
| Marianne Andreach | F | - | - | |
| Bryan Reasons | M | 56 | 5 Jahre | |
| Derek Belz | M | - | 2 Jahre | |
| Steven Barg | M | 62 | 1 Jahre | |
| Julien Meissonnier | M | - |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 18 Jahre |
| Stephen Rocamboli | M | 52 | 2 Jahre | |
| Karen Murphy Santiago | F | 53 | 2 Jahre | |
| Rolf Classon | M | 79 | 10 Jahre | |
| Caroline Litchfield | F | 55 | 34 Jahre | |
| Bruce McEvoy | M | 46 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 17 Jahre |
| Alan Fuhrman | M | 67 | 4 Jahre | |
| Michelle Ryan | F | 58 | 1 Jahre | |
| Patricia Russo | F | 71 | 29 Jahre | |
| Antonio Gotto | M | 88 | 10 Jahre | |
| Donald Morel | M | 67 | 9 Jahre | |
| Jay Shepard | M | 66 | 6 Jahre | |
| Gail Naughton | M | 69 | 4 Jahre | |
| Frank D'Amelio | M | 66 | 1 Jahre | |
| Gregory Lucier | M | 59 | 9 Jahre | |
| Benjamin Halladay | M | 38 | 4 Jahre | |
| Eric Warren | M | 76 | 3 Jahre | |
| Tracy Woody | F | 54 | 5 Jahre | |
| Michael Barber | M | 64 | 3 Jahre | |
| Benjamin Looker | M | 42 | 2 Jahre | |
| Lim Chin Wei | M | - | 7 Jahre | |
| Greg Bleck | M | - | 17 Jahre | |
| JoAnne Foody | M | 59 | 3 Jahre | |
| Paul Surdez | M | - | 4 Jahre | |
| Alexis Callahan | M | - | - | |
| Manja Hermina Boerman | M | 58 | 5 Jahre | |
| Lisa Evoli | F | 55 | 1 Jahre | |
| Frédéric Cédrone | M | - | 2 Jahre | |
| Glenn Brame | M | 67 | 1 Jahre | |
| Michael J. Grippo | M | 55 | 8 Jahre | |
| Aristippos Gennadios | M | 59 | - | |
| Betty Jean | F | - | 3 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Robert P. Luciano | M | - | 23 Jahre | |
| Kenneth Frazier | M | 69 | 30 Jahre | |
| Timothy Morris | M | 62 | 9 Jahre | |
| Angus Russell | M | 68 | 8 Jahre | |
| Thomas Castellano | M | 45 | 15 Jahre | |
| David Norton | M | 72 | 9 Jahre | |
| Melvin Booth | M | 79 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 8 Jahre |
| Richard Kogan | M | 81 | 21 Jahre | |
| Paul Bisaro | M | 63 | 3 Jahre | |
| Paul R. Fonteyne | M | 62 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 9 Jahre |
| Daniel Alan Cartwright | M | 66 | 9 Jahre | |
| P. Vagelos | M | 94 | 19 Jahre | |
| Steven Fasman | M | 61 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 9 Jahre |
| Mark Trudeau | M | 62 | 9 Jahre | |
| Matthew Harbaugh | M | 53 | 6 Jahre | |
| Ambrose Bailey | M | 60 | - | |
| Wetteny Joseph | M | 52 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 13 Jahre |
| Jason S. Spitz | M | - | 9 Jahre | |
| Paul Edick | M | 67 | 4 Jahre | |
| Ron Hunt | M | 59 | 5 Jahre | |
| Hugh O'Dowd | M | 59 | - | |
| Marla Persky | F | 68 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 8 Jahre |
| Scott L. Houlton | M | 57 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 7 Jahre |
| Argeris Karabelas | M | 71 |
Inotek Pharmaceuticals Corp.
 Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | 4 Jahre |
| Wendy Yarno | F | 68 | 10 Jahre | |
| Peter Y. Tam | M | 60 | 20 Jahre | |
| Michael Astrue | M | 67 | 1 Jahre | |
| David Southwell | M | 63 |
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | 4 Jahre |
| Robert Wilson | M | 83 | 1 Jahre | |
| Mark B. Logan | M | 84 | 15 Jahre | |
| Raymond Gilmartin | M | 82 | 2 Jahre | |
| Sandra L. Hatten | F | 67 | 5 Jahre | |
| Laura Sepp-Lorenzino | M | 63 | 15 Jahre | |
| Michael Herrman | M | 56 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 16 Jahre |
| Larry G. Edwards | M | 52 | 15 Jahre | |
| Caroline Dorsa | F | 64 | 22 Jahre | |
| Richard Henriques | M | 68 | 27 Jahre | |
| Isai Peimer | M | 46 |
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | 3 Jahre |
| Joseph Romanelli | M | 50 | 19 Jahre | |
| Will Downie | M | 57 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 10 Jahre |
| William Harrison | M | 80 | - | |
| Richard Markham | M | 73 | 20 Jahre | |
| Kenneth Bartizal | M | 72 | 20 Jahre | |
| Anne Tatlock | F | 84 | - | |
| William McVicar | M | 66 |
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | 10 Jahre |
| Thomas Shenk | M | 77 | 11 Jahre | |
| Henry W. Gadsden | M | - | 11 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 93 | 93,94% |
| Irland | 10 | 10,10% |
| Deutschland | 0 | -.--% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- J. Carroll
- Persönliches Netzwerk
